Category: Pharmaceuticals
North America Pharmaceuticals
-
Clinical Rollators
... at a CAGR of 5.0% over the analysis period 2023-2030. 4-Wheeler Rollators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$262.0 Million by the end of ... Read More
-
Online Home Rental Services
... reach US$65.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2023-2030. Flats, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$36.3 ... Read More
-
Cognitive Computing
... at a CAGR of 27.6% over the analysis period 2023-2030. Natural Language Processing Technology, one of the segments analyzed in the report, is expected to record a 25.2% CAGR and reach US$159.0 Billion by the ... Read More
-
Human Papillomavirus (HPV) Testing
... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More
-
Hybrid and Electric Vehicle Fuses
... is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 24.4% over the analysis period 2023-2030. Hybrid Electric Vehicles (HEVs) Application, one of the segments analyzed in the report, is expected to ... Read More
-
Gluten Free Products
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Gluten Free Bakery Products, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.7 ... Read More
-
Swine Health
... at a CAGR of 5.8% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Hair Transplant Services
... by 2030, growing at a CAGR of 14.2% over the analysis period 2023-2030. Platelet-Rich Plasma Therapy, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$7.0 Billion ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
Gensets
... of 5.6% over the analysis period 2023-2030. Diesel Gensets, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.1 Billion by the end of the analysis period. ... Read More
-
Hepatitis B Vaccines
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Adult Application, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.7 Billion by ... Read More
-
Home Care Services
... by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Maid Services, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$22.7 Billion by ... Read More
-
Hydroponics
... of 14.2% over the analysis period 2023-2030. Aggregate Systems, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$8.1 Billion by the end of the analysis period. ... Read More
-
Family Planning Centers
... by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion ... Read More
-
Spring and Wire Products
... reach US$82.0 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$47.0 ... Read More
-
Kidney Dialysis Centers
... B Braun (both based in Germany). COMPETITIVE LANDSCAPE Demand depends on the number of people who suffer from kidney disease. The profitability of individual companies is linked to efficient operations and good marketing. Large companies ... Read More
-
Herbal/Traditional Products in Canada
... wary of the potential effects of using artificial chemicals, especially over the longer term, and turning to more natural alternatives. Herbal/traditional topical analgesics is expected to lead growth, with rising demand primarily being driven by ... Read More
-
Dietary Supplements in Canada
... probiotic supplements recording notable growth underpinned by consumers’ continued interest in gut health and general wellness. There is growing awareness of the role of the gut microbiome in overall health and wellbeing, which is supporting ... Read More
-
NRT Smoking Cessation Aids in Canada
... the related attempts to reduce or quit smoking, which often takes multiple attempts and can involve consumption of multiple products such as patches and gum as consumers look for the most effective solution. Euromonitor’s Voice ... Read More
-
Vitamins in Canada
... the experience of the COVID-19 crisis and in the context of the stress caused by challenging economic conditions and an increase in the cost of living. In general, the health and wellness trend has shifted ... Read More
-
Paediatric Consumer Health in Canada
... as these categories continue to normalise after the massive spike in demand in 2022, which was caused by the flu/RSV/COVID “triple-demic” and led to shortages of such products. In 2024, most regions of Canada saw ... Read More
-
Analgesics in Canada
... previous year as demand began to normalise after the sharp increase in demand for pain relief in 2022 as respiratory syncytial virus (RSV), the flu and COVID-19 circulated amongst Canadians. Consumers bought analgesics in 2023 ... Read More
-
Dermatologicals in Canada
... the drivers that were predominating prior to the outbreak of COVID-19, including Canada’s ageing population, which is helping to drive growth in categories such as haemorrhoid treatments. Older Canadians are more prone to haemorrhoids due ... Read More
-
Consumer Health in Canada
... marked by extreme demand and cough, cold and analgesics shortages caused by the “triple-demic” of flu, respiratory syncytial virus (RSV) and COVID-19. Growth is expected despite headwinds from an inflation-driven higher cost of living including ... Read More
-
Sleep Aids in Canada
... Voice of the Consumer: Health and Nutrition Survey showed respondents had increased concern over sleeping problems in 2024, with 10% of respondents being extremely concerned with sleeping problems compared to 8% in 2023, while 35% ... Read More
Research Assistance
